Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism: no.
Kovacs
M J
MJ
Department of Hematology, London Health Sciences Center, London, Ontario, Canada. michael.kovacs@lhsc.on.ca
D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring / Q000592:standards; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D018570:Risk Assessment; D055502:Secondary Prevention; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D014859:Warfarin